To Association of Serum Ferrtin and Homocysteine Levels With Insulin Resistence and Metabolic Syndrome in Women With Polycystic Ovary Syndrome
N/A
18 Years
45 Years
18 Years
45 Years
Open (Enrolling)
Female
Polycystic Ovary Syndrome
Female
Polycystic Ovary Syndrome
Trial Information
To Association of Serum Ferrtin and Homocysteine Levels With Insulin Resistence and Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Inclusion Criteria:
- female patients who had been performed with fully PCOS-related survey Who visited the
Reproductive Endocrinology Clinic at the Wan Fang Medical Center at Taipei Medical
University from Jan 1, 2008, to November 30, 2011.
Exclusion Criteria:
- women who had been diagnosed with disorders of the uterus (e.g., Asherman's Syndrome,
Mullerian agenesis), and chromosomal anomalies (e.g., Turner syndrome)
- women who had menopause
- women with inadequate clinical/biochemical records
- women who had had ovarian cysts or ovarian tumors
- women who took hormone, medicine for Diabetes and/or cardiovascular disease.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Authority:
Taiwan: Department of Health
Study ID:
WFH-TMU-PCOS-201111006
NCT ID:
NCT01600833
Start Date:
March 2012
Completion Date:
March 2013
Related Keywords:
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome(PCOS)
- Ferritin
- Homocysteine
- Insulin Resistance(RI)
- Metabolic Syndrome(MS)
- the patients have PCOS who visited the Reproductive Endocrinology Clinic at the WanFang Medical Center from Jan 1, 2008 to Nov 30, 2011.
- Polycystic Ovary Syndrome
- Metabolic Syndrome X
Name | Location |
|---|
